Business Context and Reporting Period
Company: OptimizeRx Corporation (OPRX)
Filing Type: Form 8-K (Current Report)
Report Date: November 6, 2025
Reporting Period: Third Quarter ended September 30, 2025
Business Context: The filing announces the release of financial results for the third quarter of 2025 via a press release (Exhibit 99.1).
Key Financial Metrics
The provided text is a cover page and index for the Form 8-K. It references a press release containing the actual financial data but does not include the specific figures within this document.
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Material Changes
The filing text does not provide specific data to compare against the prior comparable period. Material changes, if any, are detailed in the referenced press release (Exhibit 99.1) which is not included in the input content.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the issuance of a press release regarding Q3 2025 results but does not contain the commentary itself.
Guidance and Outlook: Not provided in this text.
Risks and Contingencies: Not provided in this text.
Unusual Items: Not provided in this text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q3 2025 revenue, net income, and cash flow figures.
- Verify year-over-year and quarter-over-quarter performance metrics in the full press release.
- Check for any updated forward-looking guidance or strategic shifts mentioned in the press release.
- Confirm the status of the company's emerging growth company election and any related accounting standard transitions.